Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cyclerion Therapeutics (NASDAQ:CYCN) through any online brokerage.
Other companies in Cyclerion Therapeutics’s space includes: Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX), TransCode Therapeutics Inc (NASDAQ:RNAZ) and Indaptus Therapeutics Inc (NASDAQ:INDP).
There is no analysis for Cyclerion Therapeutics to provide a consensus price target.
The stock price for Cyclerion Therapeutics (NASDAQ: CYCN) is $1.33 last updated January 15, 2026 at 5:29 PM EST.
There are no upcoming dividends for Cyclerion Therapeutics.
Cyclerion Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Cyclerion Therapeutics.
Cyclerion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.